Image
Stories
Mid-large buyout
Investments
We offer everything our portfolio companies need to grow: the insights of our committed experts, in-depth industry knowledge, prime access to global markets and a responsible approach to value creation. We have developed a diversified portfolio across various sectors of activity, including today’s top performers and the unicorns and leaders of tomorrow. It is built for success in both the short and long term.
Non-exhaustive portfolio.
Stories
Blocs de la page
229 result(s)
229 result(s)
Vivet
Gene therapy biotech company.
Healthcare - Kurma Partners
StatusIn portfolio
Investment date04/2017
SectorHealthcare
LocationEurope
Actility
Provider of LPWA networks and application softwares for the IoT
Venture - Smart city
StatusIn portfolio
Investment date04/2017
SectorTech-enabled
LocationEurope
Carambar & Co
French confectionary group
Mid-large buyout
StatusIn portfolio
Investment date05/2017
SectorConsumer
LocationEurope
CMP Paris
Importer and manufacturer of kitchen, decoration, toys and high tech products
Corporate Financing
StatusIn portfolio
Investment date05/2017
SectorConsumer
LocationEurope
Peters Surgical
Manufacturer of single-use sterelized surgical devices
Small-mid buyout
StatusIn portfolio
Investment date05/2017
SectorHealthcare
LocationEurope
Smile
French leading player in digital transformation focusing on open source solutions
Small-mid buyout
StatusIn portfolio
Investment date05/2017
SectorTech-enabled
LocationEurope
Information - Individual investors
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)